Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuxun Liu

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Immunology Letters|March 20, 2003
Cloning and identification of a novel ubiquitin-like protein, BMSC-UbP, from human bone marrow stromal cellsShuxun Liu, Yizhi Yu, Huazhang An, et al.
Clinical Immunology (Orlando, Fla.)|August 8, 2008
TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patientsPingping Wu, Jiang Wu, Shuxun Liu, et al.
Translational Cancer Research|February 20, 2025
Immune checkpoint inhibitors plus paclitaxel-based chemotherapy <i>vs.</i> oxaliplatin-based therapy as first-line treatment for patients with HER2-negative unresectable or metastatic gastric/gastroesophageal junction cancer: results of a multicenter retrospective studyYulu Fang, Yifan Zhao, Xiaoling Zhang, et al.
Biochemical and Biophysical Research Communications|January 1, 2003
Cloning and identification of a novel human ubiquitin-like protein, DC-UbP, from dendritic cellsShuxun Liu, Huazhang An, Nan Li, et al.
Nature Immunology|April 9, 2008
Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1Huazhang An, Jin Hou, Jun Zhou, et al.
Journal of Gastrointestinal Oncology|May 17, 2024
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective studyYulu Fang, Yifan Zhao, Xiaofu Yu, et al.
Journal of Gastrointestinal Oncology|September 16, 2024
<i>LDHA</i> as a predictive biomarker and its association with the infiltration of immune cells in pancreatic adenocarcinomaQiuqing Zheng, Yingjun Xie, Luyin Xu, et al.
Blood|September 10, 2009
Fibronectin maintains survival of mouse natural killer (NK) cells via CD11b/Src/beta-catenin pathwayTing Zhang, Shuxun Liu, Pengyuan Yang, et al.
Journal of Autoimmunity|May 22, 2023
Metabolic enzyme Suclg2 maintains tolerogenicity of regulatory dendritic cells diffDCs by suppressing Lactb succinylationXiaomin Zhang, Juan Liu, Yujie Cheng, et al.
Cancer Research|December 18, 2003
Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosisRunzi Qi, Huazhang An, Yizhi Yu, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Immunology Letters|March 20, 2003
Cloning and identification of a novel ubiquitin-like protein, BMSC-UbP, from human bone marrow stromal cellsShuxun Liu, Yizhi Yu, Huazhang An, et al.
Clinical Immunology (Orlando, Fla.)|August 8, 2008
TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patientsPingping Wu, Jiang Wu, Shuxun Liu, et al.
Translational Cancer Research|February 20, 2025
Immune checkpoint inhibitors plus paclitaxel-based chemotherapy <i>vs.</i> oxaliplatin-based therapy as first-line treatment for patients with HER2-negative unresectable or metastatic gastric/gastroesophageal junction cancer: results of a multicenter retrospective studyYulu Fang, Yifan Zhao, Xiaoling Zhang, et al.
Biochemical and Biophysical Research Communications|January 1, 2003
Cloning and identification of a novel human ubiquitin-like protein, DC-UbP, from dendritic cellsShuxun Liu, Huazhang An, Nan Li, et al.
Nature Immunology|April 9, 2008
Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1Huazhang An, Jin Hou, Jun Zhou, et al.
Journal of Gastrointestinal Oncology|May 17, 2024
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective studyYulu Fang, Yifan Zhao, Xiaofu Yu, et al.
Journal of Gastrointestinal Oncology|September 16, 2024
<i>LDHA</i> as a predictive biomarker and its association with the infiltration of immune cells in pancreatic adenocarcinomaQiuqing Zheng, Yingjun Xie, Luyin Xu, et al.
Blood|September 10, 2009
Fibronectin maintains survival of mouse natural killer (NK) cells via CD11b/Src/beta-catenin pathwayTing Zhang, Shuxun Liu, Pengyuan Yang, et al.
Journal of Autoimmunity|May 22, 2023
Metabolic enzyme Suclg2 maintains tolerogenicity of regulatory dendritic cells diffDCs by suppressing Lactb succinylationXiaomin Zhang, Juan Liu, Yujie Cheng, et al.
Cancer Research|December 18, 2003
Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosisRunzi Qi, Huazhang An, Yizhi Yu, et al.
Pageof 9